<?xml version="1.0" encoding="UTF-8"?>
<p>While prior infection history will have to be documented through viral diagnostic or serological assays such as Rapid Diagnostic Tests before vaccination, it is of course not intended to assess the level and specificity of individual neutralizing responses through quantitative assays such as PRNT
 <sub>50</sub>. One can however, based on clinical evidence across a large number of studies [
 <xref rid="B36-vaccines-08-00174" ref-type="bibr">36</xref>], propose that after the refractory period, pre-existing responses would in majority enhance vaccine immunogenicity.
</p>
